Intra-Cellular Therapies, Inc. Annual Return On Assets in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Return On Assets history and growth rate from 2013 to 2023.
  • Intra-Cellular Therapies, Inc. Return On Assets for the quarter ending September 30, 2024 was -8.38 %, a 60.7% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2023 was -19.4 %, a 39.1% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2022 was -31.9 %, a 34.2% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2021 was -48.4 %, a 28.6% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -19.4 +12.5 +39.1% Jan 1, 2023 Dec 31, 2023
2022 -31.9 +16.6 +34.2% Jan 1, 2022 Dec 31, 2022
2021 -48.4 -10.8 -28.6% Jan 1, 2021 Dec 31, 2021
2020 -37.7 +12.2 +24.5% Jan 1, 2020 Dec 31, 2020
2019 -49.9 -11.1 -28.7% Jan 1, 2019 Dec 31, 2019
2018 -38.8 -13.2 -51.4% Jan 1, 2018 Dec 31, 2018
2017 -25.6 -0.33 -1.31% Jan 1, 2017 Dec 31, 2017
2016 -25.3 +3.68 +12.7% Jan 1, 2016 Dec 31, 2016
2015 -29 -6.9 -31.3% Jan 1, 2015 Dec 31, 2015
2014 -22.1 +103 +82.4% Jan 1, 2014 Dec 31, 2014
2013 -125 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.